Dual BET and CBP/p300 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual BET and CBP/p300 inhibitor, covering 2025-01-14 to 2025-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies [Phase 1]